Enliven Therapeutics
PublicLast Round
Follow-on Offering
Jun 16, 2025
Total Funding Raised
$540M
Company Overview
Enliven Therapeutics (NAS: ELVN) is a clinical-stage precision oncology company specializing in the discovery and development of innovative therapies aimed at addressing challenges in cancer treatment, including tolerability and resistance.
Sector
Healthcare/Wellness
AI Layer
Non-AI
Keywords
small molecule kinase inhibitorsprecision oncology therapeuticsBCR-ABL kinase inhibitor for CMLtherapies for treatment-resistant cancerHER2 inhibitor for solid tumorsCNS-penetrant cancer therapygenetically-defined cancer therapiesChronic Myeloid Leukemia (CML) treatmentoral small molecule cancer drugtherapies for HER2-mutated cancersoncology drug discovery and developmentclinical-stage biopharmaceutical company
Enliven Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Enliven Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Follow-on Offering | Jun 16, 2025 | ||||
| Private Placement | Mar 21, 2024 | ||||
| Reverse Merger | Feb 23, 2023 | ||||
| Series A | Dec 7, 2020 |
Enliven Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Jefferies | Follow-on Offering |
| Janus Henderson Group | Series A |
| RA Capital Management | Reverse Merger |
| Fidelity Management & Research Company | Reverse Merger |
| Fairmount Ventures | Reverse Merger |
| OrbiMed | Series A |
| 5AM Ventures | Series A |
Enliven Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Firmographic Details
HeadquartersBoulder, Colorado
Employee Range70
Year Founded2019
Last FundingJun 16, 2025